Immune peptides
Thymosin Alpha-1
- 10 mg
Custom strengths on request
Not FDA-approved. Not on FDA's 503A category lists (May 14, 2026). Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
1.6 mg subcutaneously twice a week (hepatitis B or C label dose)
Approved label
- Frequency
- twice a week
- Route
- subcutaneous (not intravenous)
- Course
- 6 to 12 months (hepatitis B); 12 months (hepatitis C)
Label vial is 1.6 mg; the 10 mg formulary vial is 6.25x stronger, so write dose in mg and mL.
Get a quote
Custom strengths on request. Prices are quoted per clinic.